Loading...
Loading...
NEW YORK, NY · CIK 0001601086
New positions
169
Added to
70
Trimmed
64
Exited
97
Source: SEC 13F-HR filing filed on 2026-08-14 ·View on SEC.gov →
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | MDGLMADRIGAL PHARMACEUTICALS INC | $154.64M | 4.28% | +8.9% |
| 2 | SUPNSUPERNUS PHARMACEUTICALS | $123.07M | 3.40% | +39.6% |
| 3 | CYTKCYTOKINETICS INC | $102.34M | 2.83% | +57.1% |
| 4 | INCYINCYTE CORP | $102.02M | 2.82% | +37.0% |
| 5 | NBIXNEUROCRINE BIOSCIENCES INC | $90.31M | 2.50% | -26.0% |
| 6 | TVTXTRAVERE THERAPEUTICS INC | $89.34M | 2.47% | -67.9% |
| 7 | AGIOAGIOS PHARMACEUTICALS INC | $89.06M | 2.46% | -11.6% |
| 8 | PTCTPTC THERAPEUTICS INC | $87.39M | 2.42% | -48.4% |
| 9 | UNHUNITEDHEALTH GROUP INC | $76.06M | 2.10% | +23.6% |
| 10 | FRPTFRESHPET INC | $74.53M | 2.06% | +15.3% |
| Stock | Value | Shares |
|---|---|---|
| WATWATERS CORP | $28.13M | 75,004 |
| ILMNILLUMINA INC | $16.02M | 91,118 |
| PBHPRESTIGE CONSMR HEALTHCARE I | $15.88M | 336,000 |
| FWONKLIBERTY MEDIA CORP DEL | $15.71M | 165,106 |
| ITGRINTEGER HLDGS CORP | $15.68M | 167,746 |
| LYVLIVE NATION ENTERTAINMENT IN | $14.98M | 81,824 |
| NVONOVO-NORDISK A S | $14.96M | 312,000 |
| TWSTTWIST BIOSCIENCE CORP | $14.61M | 142,000 |
| TTWOTAKE-TWO INTERACTIVE SOFTWAR | $12.47M | 49,877 |
| MRVLMARVELL TECHNOLOGY INC | $11.91M | 39,978 |
As of Q2 2026, ARMISTICE CAPITAL, LLC reported a portfolio value of $3.61B across 323 positions in their 13F filing.
ARMISTICE CAPITAL, LLC's largest holding is MDGL with a position worth $154.64M. Their top holdings include MDGL, SUPN, CYTK, INCY, NBIX.
In Q2 2026, ARMISTICE CAPITAL, LLC made the following changes to their portfolio: 169 new positions, 97 positions sold out, 70 positions increased, 64 positions reduced.
ARMISTICE CAPITAL, LLC files quarterly 13F reports with the SEC, disclosing their long positions in U.S. equities. These filings are due within 45 days of the quarter end and provide transparency into their investment strategy and portfolio allocation.
Get alerts when ARMISTICE CAPITAL, LLC files new 13F holdings.